SCHEMBL29771861

SCHEMBL29771861

CN1CCc2cc(OC(F)F)c([N+](=O)[O-])cc2C1=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ GRM5 P41594 1/20 0.36
▸ RAB9A P51151 1/20 0.35
▸ AOC3 Q16853 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SIRT6 Q8N6T7 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205991 0.85 MEN1 (0.69) MEN1KMT2AGRM5RAB9ASMN1; SMN2
SCHEMBL30242551 0.85 MEN1 (0.69) MEN1KMT2AGRM5RAB9ASMN1; SMN2
SCHEMBL30242496 0.79 MEN1 (0.49) MEN1KMT2AGRM5AOC3SMN1; SMN2
SCHEMBL28929559 0.79 MEN1 (0.49) MEN1KMT2AGRM5AOC3SMN1; SMN2
SCHEMBL27156530 0.78 MEN1 (0.50) MEN1KMT2AGRM5ALDH1A1
SCHEMBL24869491 0.78 MAOA (0.49) RAB9ASMN1; SMN2MAPTLMNAHTT
SCHEMBL29771864 0.78 MAOA (0.49) RAB9ASMN1; SMN2MAPTLMNAHTT
SCHEMBL20214438 0.78 KMT2A (0.58) MEN1KMT2ARAB9ASMN1; SMN2GAA
SCHEMBL29771862 0.77 KMT2A (0.49) MEN1KMT2AGRM5AOC3MAPT
SCHEMBL25947319 0.73 MEN1 (0.46) MEN1KMT2AGRM5AOC3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274829-A1 THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF Ontario Institute for Cancer Research (OICR) (CA) 2023-11-15 — — EP disclosed
CN-116981664-A Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of NUAK kinase, compositions and uses thereof 安大略省癌症研究所(OICR) 2023-10-31 — — CN disclosed
WO-2022147620-A1 THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-07-14 — — WO disclosed
Send feedback